Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.
about
Lung cancer susceptibility model based on age, family history and genetic variantsApoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancerGenetic susceptibility to lung cancer--light at the end of the tunnel?Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesA test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in casesLung Cancer: Are we up to the Challenge?International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variantsSingle nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerEmerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyIncremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data.Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cellsIL1 receptor antagonist gene IL1-RN variable number of tandem repeats polymorphism and cancer risk: a literature review and meta-analysis.Lymphotoxin-alpha polymorphisms and presence of cancer in 1,536 consecutive autopsy casesHLungDB: an integrated database of human lung cancer research.Body mass index and smoking-related lung cancer risk in the Singapore Chinese Health Study.Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization.C-reactive protein and risk of lung cancer.Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.Genetic variants in inflammation pathway genes and asthma in glioma susceptibility.C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysisAssociation between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysisChemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactionsRole of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.The BATTLE to personalize lung cancer prevention through reverse migration.Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.A two-SNP IL-6 promoter haplotype is associated with increased lung cancer riskGenetic epidemiology of cigarette smoke-induced lung disease.Molecular epidemiology, cancer-related symptoms, and cytokines pathway.The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals.Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk.Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokersGenetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patientsSystems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 statusA Single Nucleotide Polymorphism in the Phospholipase D1 Gene is Associated with Risk of Non-Small Cell Lung Cancer.Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.
P2860
Q21091204-2BCC6CE2-33E7-4016-9330-E9B18DDA1E41Q23918557-59950256-673B-468A-B45C-74FA71481E3AQ26852320-5313442C-4479-42AF-8495-202327ED7B95Q27023830-C3E09642-22DE-40F8-A850-2B9AE7579733Q28384749-C8F4E922-0F5C-4D25-8132-282E1AE1F90DQ28386607-C428C7EB-6819-419F-870F-F2938255ED37Q28394515-A61DDDD9-CE3D-401C-AF81-D183279C0C03Q28816916-1BBE8B18-B4BE-48F5-BE11-790A7E799F97Q30438965-693FC800-D59D-4559-A676-15D0A1558B0BQ30492213-EE15652D-693C-4CF4-88BA-0C350B53850FQ30845849-70A6A619-57D1-425D-AE3E-CFBB8FC72B93Q31103501-5C00C25A-7AA0-4D3D-BB69-E88C60BE8EADQ33359870-5CE987D8-6304-4C23-8A8F-83381DE69D9BQ33600989-90089CC8-6903-4C73-B877-BE3F55EA8691Q33658535-6C3F0DF6-04FB-4213-A0CF-E6996A1DD663Q33682155-9E0AC4BC-3AC4-4DAC-912B-42DA33A59408Q33837125-5E140DB1-231C-4C5C-9228-4759626FC814Q33882555-7E1C2597-E53C-4667-A9AC-F5461DEE5AE4Q33898168-770684B7-7D06-4E2C-9D30-54375429EB8FQ34030497-23D1B123-4415-4307-BD4C-B26131942681Q34101144-9919F29D-D1AF-493F-BE67-2F2C16720FA6Q34132866-0B4AEE06-3A94-469E-9748-ACFC326DEF2FQ34389236-4CD0DA9D-77EE-4508-BA1A-A5CBF5782FBCQ34430876-73311357-AFD4-443D-95D2-471B9181C4B5Q34477550-5BDD242A-D6A3-4072-A1D0-7D2CC5608B63Q35120883-991342F0-38EB-486E-9FFB-CCA8197E1CD2Q35208501-541D741E-12D1-4DF2-9D57-DE6178C829FDQ35261110-840CB564-B435-4177-AAD8-EFA8482BBF15Q35613331-E310AB9E-3F6C-4321-A11D-FB678E586750Q35950161-0DD241E1-C44A-4723-89CA-CA0365D59354Q35984048-7CF10BB6-10AA-4DAD-BFA6-BDB6C8DA373CQ36079191-E51E76AE-77C0-446F-BCD1-2281340A44A9Q36172908-EB989F36-4504-452B-A2DA-D3058D02B8A7Q36224715-46E1BD33-6552-4FC7-A491-64ABC21D3B09Q36360694-DBBA8E66-C208-4817-A438-A72359CF131DQ36367063-2205EB3F-FD1D-4A93-A16F-CE9ECE1136C7Q36625873-9DD69EB0-FC0F-443A-BF73-EEDED6A616A5Q36678582-6C5132A6-8B98-43BA-A45A-F384D969F828Q36735743-C7904C30-06E7-421C-98A6-552E95F65C01Q36773349-4B55A987-C6A6-4252-8461-26BD131B08C6
P2860
Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Systematic evaluation of genet ...... thway and risk of lung cancer.
@ast
Systematic evaluation of genet ...... thway and risk of lung cancer.
@en
Systematic evaluation of genet ...... thway and risk of lung cancer.
@nl
type
label
Systematic evaluation of genet ...... thway and risk of lung cancer.
@ast
Systematic evaluation of genet ...... thway and risk of lung cancer.
@en
Systematic evaluation of genet ...... thway and risk of lung cancer.
@nl
prefLabel
Systematic evaluation of genet ...... thway and risk of lung cancer.
@ast
Systematic evaluation of genet ...... thway and risk of lung cancer.
@en
Systematic evaluation of genet ...... thway and risk of lung cancer.
@nl
P2093
P1433
P1476
Systematic evaluation of genet ...... athway and risk of lung cancer
@en
P2093
Eric A Engels
Margaret R Spitz
Qiong Dong
P304
P356
10.1158/0008-5472.CAN-07-0370
P407
P50
P577
2007-06-27T00:00:00Z